|
|
40
|
3653CT
|
NASONEX 50MCG NASAL SP (MSD/STO) MOMETASONE
|
120 DOSES
|
C
|
17.07
|
50MCG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
3653CT
|
NASONEX 50MCG NASAL SP (MSD) MOMETA (C)
|
120 DOSES
|
C
|
17.2614
|
50MCG
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
3653CT
|
NASONEX 50MCG NASAL SP (MSD) MOMET (C)
|
120 DOSES
|
C
|
17.26
|
50MCG
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
41
|
3653CW
|
APO-MOMETASONE 50MCG NASAL SP (APO)
|
140 DOSES
|
A
|
7.8288
|
50MCG
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
3653DG
|
NEOTISON 27.5MCG NASAL SP (INC) FLUTICASONE
|
120 DOSES
|
A
|
8.97
|
27.5MCG
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
42
|
3653DK
|
FLUBREATH 50MCG NASAL SP (JLP) FLUTICASONE
|
120 DOSES
|
A
|
4.57
|
50MCG
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
42
|
3653DL
|
NAZERELIEF 50MCG NASAL SP (JLP) MOMETASONE
|
100 DOSES
|
A
|
2.20
|
50MCG
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
3653P
|
FLIXONASE 50MCG NASAL SP (GSK/COL) FLUTICASON
|
120 DOSES
|
A
|
12.91
|
50MCG
|
1
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
3653P
|
FLIXONASE 50MCG NASAL SP (GSK) FLUTICASO
|
120 DOSES
|
A
|
13.6732
|
50MCG
|
1
|
2024-04-01
|
2024-07-25
|
|
|
|
6
|
|
|
40
|
3653T
|
NASACORT AQ 55MCG NASAL SP (SFA/COL) TRIAMCIN
|
120 DOSES
|
A
|
12.23
|
55MCG
|
1
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
40
|
36551
|
BRIXIA 0.05% EYE DR (LPO/COL) AZELASTINE
|
6ML
|
A
|
6.25
|
0.05%
|
1
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
36551
|
BRIXIA 0.05% EYE DR (LPO) AZELASTINE
|
6ML
|
A
|
6.8774
|
0.05%
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
36551
|
BRIXIA 0.05% EYE DR (LPO) AZELASTINE
|
6ML
|
A
|
19.03
|
0.05%
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
36613
|
LIPOFUNDIN 20% INJ (BRA/COL) SOYA BEAN OIL
|
500ML
|
BQ
|
34.39
|
20%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
36613
|
LIPOFUNDIN 20% INJ (BRA) SOYA BEAN OIL
|
500ML
|
BQ
|
41.2642
|
20%
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
36613
|
LIPOFUNDIN 20% INJ (BRA) SOYA BEAN OIL
|
500ML
|
BQ
|
65.24
|
20%
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
3681G
|
NALOXONE 0.4MG/ML INJ (RTM/PHA)
|
10X1ML
|
BQ
|
4.925
|
0.4MG/ML
|
|
2022-04-01
|
2024-03-31
|
No
|
No
|
Add to Contract as Cat B
|
|
|
|
41
|
3681G
|
NALOXONE 0.4MG/ML INJ (RTM) (B)
|
10X1ML
|
B
|
5.7302
|
0.4MG/ML
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
3681G
|
NALOXONE 0.4MG/ML INJ (RTM)
|
10X1ML
|
B
|
4.08
|
0.4MG/ML
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
41
|
3681Q
|
N-XONE 0.4MG/ML INJ (VEV) NALOXONE (B)
|
10X1ML
|
B
|
4.7299
|
0.4MG/ML
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|